XML 54 R40.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation (Tables)
12 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Allocation of Share-based Compensation Costs by Plan The following table presents a summary of stock-based compensation expense related to stock options and restricted stock awards for the periods presented.
Fiscal Year Ended September 30,
in thousands202520242023
Stock options expense$7 $$— 
Restricted stock awards expense7,331 7,390 7,275 
Stock-based compensation expense$7,338 $7,391 $7,275 
Schedule of Stock Options Activity
Following is a summary of stock option activity for the periods presented:
Fiscal Year Ended September 30,
 202520242023
 SharesWeighted-
Average
Exercise
Price
SharesWeighted-
Average
Exercise
Price
SharesWeighted-
Average
Exercise
Price
Outstanding at beginning of period11,150 $10.04 13,575 $9.61 27,507 $14.31 
Granted1,692 22.38 50 27.73 100 27.98 
Exercised(11,000)9.79 (2,475)8.08 (13,796)19.00 
Forfeited(200)20.27 — — (236)16.58 
Outstanding at end of period1,642 $23.14 11,150 $10.04 13,575 $9.61 
Exercisable at end of period100 $27.98 11,000 $9.79 13,475 $9.48 
Schedule of Assumptions for Stock Option Activity For the Company and each member of the peer group, the following inputs were used, as applicable, in the Monte Carlo valuation model to determine the fair value as of the grant date for performance-based restricted stock granted in each of the fiscal years ended.
Fiscal Year Ended September 30,
202520242023
Expected volatility range
36.3% - 82.7%
32.5% - 84.6%
41.5% - 86.9%
Risk-free interest rate4.22 %4.57 %4.26 %
Dividend yield — — 
Grant-date stock price range
$10.49 - $179.41
$9.81 - $142.79
$10.31 - $93.50
Schedule of Nonvested Stock Awards and Performance Shares
Activity relating to all restricted stock awards for the periods presented is as follows:
Fiscal Year Ended September 30, 2025
 Performance-BasedTime-BasedTotal
 SharesWeighted-
Average
Grant
Date Fair
Value
SharesWeighted-
Average
Grant
Date Fair
Value
SharesWeighted-
Average
Grant
Date Fair
Value
Beginning of period303,712 $19.48 415,787 $19.89 719,499 $19.72 
Granted96,603 36.86 229,186 31.03 325,789 32.76 
Vested(71,470)23.36 (228,863)19.89 (300,333)20.72 
Forfeited(a)
(21,748)23.51 (14,085)26.36 (35,833)24.63 
End of period307,097 $23.76 402,025 $26.01 709,122 $25.04 
(a) During the fiscal year ended September 30, 2025, 17,875 of the 89,345 performance-based shares issued under the fiscal 2022 performance-based award plan were forfeited by the holders of the awards based on the performance level achieved under the terms of the plan.
Fiscal Year Ended September 30, 2024
 
Performance-Based(a)
Time-BasedTotal
 SharesWeighted-
Average
Grant
Date Fair
Value
SharesWeighted-
Average
Grant
Date Fair
Value
SharesWeighted-
Average
Grant
Date Fair
Value
Beginning of period348,223 $16.20 593,834 $14.15 942,057 $14.91 
Granted183,396 20.80 202,042 27.14 385,438 24.12 
Vested (210,176)15.24 (336,821)14.37 (546,997)14.70 
Forfeited(17,731)18.96 (43,268)17.92 (60,999)18.22 
End of period303,712 $19.48 415,787 $19.89 719,499 $19.72 
(a) Grant and vesting activity during the fiscal year ended September 30, 2024 include 108,108 shares that were issued above target based on performance level achieved under performance-based restricted stock vesting in the current period.

Fiscal Year Ended September 30, 2023
 
Performance-Based(a)
Time-BasedTotal
 SharesWeighted-
Average
Grant
Date Fair
Value
SharesWeighted-
Average
Grant
Date Fair
Value
SharesWeighted-
Average
Grant
Date Fair
Value
Beginning of period436,146 $17.76 412,042 $18.52 848,188 $18.13 
Granted249,534 14.17 425,398 12.05 674,932 12.83 
Vested(334,736)16.80 (234,218)18.02 (568,954)17.30 
Forfeited(2,721)15.20 (9,388)14.38 (12,109)14.56 
End of period348,223 $16.20 593,834 $14.15 942,057 $14.91 
(a) Grant and vesting activity during the fiscal year ended September 30, 2023 include 92,104 shares that were issued above target based on performance level achieved under performance-based restricted stock vesting in the current period.